MDMA Moves from Party Drug Back to Thera...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ... Show More

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ... Show More

In this episode, host Rachel Feltman interviews neuroscientist Kauê M. Costa, who is among Scientific American’s inaugural cohort of Young American Scientists honorees. Costa shares how being surprised by experiments has led him to new ways of thinking about learning in the brain ... Show More

The party drug MDMA could soon be approved for treating people with severe PTSD. Learn more about your ad choices. Visit megaphone.fm/adchoices 

The FDA is about to announce whether it’s going to approve MDMA as a treatment for PTSD. Our friends at Today, Explained explore what this kind of therapy looks like, and why it’s so controversial. For show transcripts, go to vox.com/unxtranscripts For more, go to vox.com/unexpla ... Show More

<p>In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we ca ... Show More

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ... Show More

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ... Show More

Military veterans are unlikely collaborators with the psychedelic counterculture. The two groups’ efforts are being tested this month, when the FDA is poised to announce whether or not it’ll approve MDMA for PTSD. This episode was reported and produced by Haleema Shah, edited by ... Show More

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ... Show More

<p>Psychedelics have gotten very popular in the past few years for their therapeutic properties, but how much do you know about them? In this episode, I am going to talk about MDMA, which has a better success rate for PTSD than anything... ever! If all goes well with the FDA tria ... Show More

Claudia Hammond finds out how MDMA assisted psychotherapy could help treat people with alcohol dependence. Trials are in their early stages but initial results are promising. Could this in the future be a new way to treat an addiction which ordinarily can have high relapse rates? ... Show More